Iron Deficiency: From Low Ferritin to Anemia and Who Is Most at Risk

Iron deficiency is the most common nutritional shortfall worldwide, and it can progress silently from depleted storage levels to full anemia before many people notice symptoms. Understanding where you fall on that spectrum, and whether you belong to a higher-risk group, is the first step toward a productive conversation with your doctor.

What Iron Actually Does in the Body

According to the NIH Office of Dietary Supplements (ODS), iron serves several well-established physiological roles. It is an essential component of hemoglobin, the red blood cell protein responsible for carrying oxygen from the lungs to every tissue in the body. It also forms part of myoglobin, a protein that supplies oxygen directly to muscle cells and supports muscle metabolism and healthy connective tissue. Beyond oxygen transport, iron supports physical growth and neurological development, particularly during infancy and pregnancy. The evidence for these core functions is rated strong by the ODS.

How Deficiency Develops: A Three-Stage Process

Iron deficiency does not appear overnight. It typically unfolds across three stages.

• Stage 1, depleted stores: The body's iron reserves, measured by the protein ferritin, begin to fall. There are usually no outward symptoms at this point, but a blood test can detect low ferritin before anything else changes.
• Stage 2, iron-deficient erythropoiesis: With stores running low, the body cannot produce red blood cells at full efficiency. Hemoglobin levels may still appear normal, but markers such as transferrin saturation start to drop.
• Stage 3, iron deficiency anemia: Hemoglobin falls below the threshold for anemia. Symptoms at this stage commonly include fatigue, weakness, pale skin, shortness of breath, and difficulty concentrating.

Because the early stages are largely silent, routine blood work is often the only way to catch deficiency before it becomes anemia. If you suspect a problem, ask your clinician about testing ferritin alongside a standard complete blood count.

Daily Intake Targets

The NIH ODS publishes the following Recommended Dietary Allowances for adults. Men aged 19 to 50 need 8 mg of iron per day. Women aged 19 to 50 need 18 mg per day, a higher target that reflects monthly losses from menstruation. The Tolerable Upper Intake Level for adults is 45 mg per day from food and supplements combined, based on gastrointestinal side effects at higher amounts. The ODS notes that adults in the United States with normal intestinal function have very little risk of iron overload from food alone. Higher therapeutic doses are sometimes prescribed by clinicians to replenish iron stores in people with confirmed deficiency, but that is a clinical decision, not a self-care one.

Who Is Most at Risk

Several groups face a meaningfully higher likelihood of deficiency.

• Women of reproductive age: Monthly blood loss raises iron needs significantly. The gap between the 8 mg target for men and the 18 mg target for women of the same age reflects this directly.
• Pregnant women: Iron demands increase substantially to support fetal development and expanded blood volume. The ODS rates the evidence as moderate that daily iron supplementation reduces the risk of anemia and iron deficiency during pregnancy.
• Frequent blood donors: Each whole blood donation removes a meaningful amount of iron. The ODS rates as moderate the evidence that iron supplementation helps frequent donors recover hemoglobin and iron stores faster than diet alone.
• People with certain chronic diseases: Conditions such as heart failure, chronic kidney disease, and inflammatory bowel disease can impair iron absorption or increase losses. The ODS notes limited evidence that treating iron deficiency in people with heart failure improves clinical outcomes.
• Infants and young children: Rapid growth creates high iron demand relative to body size, and breast milk alone provides limited iron after the first few months.
• Vegetarians and vegans: Plant-based diets supply only nonheme iron, which is absorbed less efficiently than the heme iron found in meat. Absorption enhancers such as vitamin C can help, but dietary planning matters.

Supplement Interactions Worth Knowing

If you take any medications or other supplements, timing around iron is important. Always talk to your doctor or pharmacist before combining iron supplements with any medication. The ODS flags the following specific interactions.

• Levodopa (Sinemet, Stalevo): Iron supplements can reduce levodopa absorption, possibly through a chelation process, and may reduce its clinical effectiveness.
• Levothyroxine (Synthroid, Levoxyl, Tirosint, Unithroid): Taking iron at the same time as levothyroxine can reduce the thyroid medication's absorption and efficacy. Product labels advise separating the two by at least 4 hours.
• Proton pump inhibitors (lansoprazole, omeprazole): These drugs lower stomach acidity, which can reduce nonheme iron absorption. People with iron deficiency who use these medications may respond less well to iron supplements.
• Calcium: Calcium may reduce the bioavailability of both heme and nonheme iron, though the ODS notes the effect is not definitively established. Some experts suggest taking calcium and iron supplements at different times as a precaution.

A Note on Supplements and Regulatory Status

Iron supplements are not intended to diagnose, treat, cure, or prevent any disease, and these statements have not been evaluated by the FDA. Supplements can play a supporting role in meeting intake targets when diet falls short, but the decision to use them, and at what dose, should be made with a clinician or pharmacist who can review your specific blood values, health history, and any medications you take. Self-diagnosing iron deficiency and starting high-dose supplements without testing is not recommended, both because symptoms overlap with many other conditions and because excess iron carries its own risks at doses above the 45 mg upper limit.

Key Takeaways

• Iron supports oxygen transport through hemoglobin and muscle oxygen supply through myoglobin, with strong evidence for both roles per the NIH ODS.
• Deficiency progresses in stages, with low ferritin appearing before anemia does.
• Women of reproductive age, pregnant women, frequent blood donors, and people with certain chronic diseases face the highest risk.
• The adult upper intake limit is 45 mg per day; higher therapeutic doses require clinical oversight.
• Several common medications interact with iron, so always consult a clinician or pharmacist before combining them.